Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics
European Pharmaceutical Review
FEBRUARY 1, 2024
For at least a decade from 2013 until recently, LDL lowering treatments were stuck on a paradigm of just putting people on statins and not getting LDL levels down to certain goals” CETP inhibitors have been around for a while, but they have unfortunately been unsuccessful in getting onto the market commercially. “For
Let's personalize your content